If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.
About 36 hours after being sworn in as the Region's new U.S. attorney, Thomas L. Kirsch II told a Crown Point civic group public corruption will remain a big target in his office's crosshairs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results